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ABSTRACT
The publication presents the results of complex research and analysis of medicinal plain-like of flora of 
Ukraine. Lycopodiophyta of Ukraine includes four families: Lycopodiaceae (8 species – Diphasiastrum alpi-
num (L.) Holub, D. complanatum (L.) Holub, D. isseleri (Rouy) Holub, D. tristachyum (Pursh) Holub, D. zeil-
leri (Rouy) Holub, Lycopodiella inundata (L.) Holub, Lycopodium annotinum L., L. clavatum L.), Huperzia-
caeae (1 – Huperzia selago (L.) Bernh. ex Schrank & C. Mart.), Selaginellaceae (2 – Selaginella helvetica (L.) 
Spring., Selaginella selaginoides (L.) C. Mart.) and Isoëtaceae (1 – Isoëtes lacustris L.). They have different 
contents of biologically active substances and all of these species are medicinal or semi-medicinal. The pa-
per presents the characteristics of their distribution in Ukraine, resource importance, population structure, 
environmental protection status in Ukraine and Europe, main active substances, and medicinal properties.
Keywords: medicinal Lycopodiophyta, resources significance, protection, Ukraine
INTRODUCTION
Nowadays, medicinal plants attract attention 
because they are among the main sources of medical 
and preventive means of non-traditional and scien-
tific modern medicine (1‒5).
One of the oldest and most interesting groups 
of plants is the representatives of Lycopodiophyta, 
which achieved their greatest development in the late 
Paleozoic. Currently it is represented by a relatively 
small number of genera and species, which account 
for only 1% of the modern species diversity of vascu-
lar plants (6‒8).
Extinct lycopods had an important role in the 
formation of coal (6,9) while modern species have 
phytogenic, industrial, decorative and medicinal val-
ue (1‒6,10‒12).
Lycopods are able to form continuous carpets 
in the woods and participate in the formation of 
plant communities, which constitutes their phyto-
genic value. Spores of Lycopods are rich in fatty oils 
and aluminum, which is a reason for their use in py-
rotechnics (for the manufacture of fireworks), met-
allurgy (for smoothness of surfaces at packed cast-
ing), in the manufacture of photos, where they are 
a source of green, blue and yellow colors. Plants are 
harvested for making bouquets and for various ritu-
als, some species of Selaginella are indoor ornamen-
tal plants (6,9,10,13).
The medicinal properties of the plants were 
noted by the ancient Romans, who considered them 
the best remedy for eliminating dullness of the skin 
(2). Nowadays, spores (lycopodium) are used as a 
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The studied species of Lycopodiophyta have no 
resource values since most species (83% or 10 species) 
in the wild are not available.
The population structure of the species is un-
stable. However, 42% (5 species) are represented by 
several individuals, which is caused by a number of 
threats, but the main one is the anthropogenic fac-
tor (cutting, grazing, recreation, etc.) to which spe-
cies are very sensitive (10,13).
All species are listed in the Red Book of Ukraine 
and require conservation measures. Most of them ‒ 
42% (5 species) — are vulnerable and only one spe-
cies (Lycopodium clavatum) is regionally rare. L. cla-
vatum and Huperzia selago are included in the Eu-
ropean Red List, to the IUCN database with LC sta-
tus, and to the European Red List of Medicinal Plants 
(13,17‒19).
The pharmacological properties of the species 
emerge due to the chemical composition and the ra-
tio of active ingredients. For medicinal purposes, 
spores and aerial parts of plants are used as raw ma-
terial. The analysis of literary data enabled us to es-
tablish that model species that are taken as the basis 
for the research of pharmacological properties usual-
ly are L. clavatum and H. selago. It is caused by their 
chemical composition, which slightly differs from 
“other composition and ratio of components”, while 
the properties, uses, and dosage forms are similar 
(1,20-24). 
The main common active substances of Lyco-
podiophyta are alkaloids (lycopodine, clavatin, lyco-
dine, etc.), flavonoids, triterpenoids, flavones, guper-
cine, carotenoids, fatty oils (spores) (1-3,5,6,11,20-38).
The spores of Lycopods contain about 50% 
non-drying fatty oil and glycerides, stearic, ole-
ic, arachidonic, palmitic and other acids, therefore, 
they are used as a powder for infants, for the treat-
ment of eczema, adulthood, bedsores, wounds, burns 
(1,2,4-6,11).
Spores and herbs are used in liver disease, respi-
ratory tract diseases, and as diuretic, antirheumatic, 
anticonvulsant and anti-inflammatory, antibacterial 
and antifungal, antiviral and antiemetic agents, etc., 
as well as for the treatment of psychological disor-
ders, Alzheimer’s disease, alcoholism and nicotine 
(1-5,11,38).
powder (as a baby powder, for treatment of bedsores), 
and for pill coating, grass lycopsids are used as a di-
uretic, anti-rheumatic, anti-inflammatory, and anes-
thetic agent, in the treatment of mental illness and 
Alzheimer’s disease; species of Huperzia are poison-
ous but used for the treatment of alcoholism and nic-
otinism (1-3,5,11,14).
Lycopodiophyta of Ukraine includes four fami-
lies: Lycopodiaceae (8 species – Diphasiastrum alpi-
num (L.) Holub, D. complanatum (L.) Holub, D. is-
seleri (Rouy) Holub, D. tristachyum (Pursh) Holub, 
D. zeilleri (Rouy) Holub, Lycopodiella inundata (L.) 
Holub, Lycopodium annotinum L., L. clavatum L.), 
Huperziacaeae (1 – Huperzia selago (L.) Bernh. ex 
Schrank & C. Mart.), Selaginellaceae (2 – Selaginel-
la helvetica (L.) Spring., Selaginella selaginoides (L.) 
C. Mart.) and Isoëtaceae (1 – Isoëtes lacustris L.) (7,8) 
are medicinal or semi-medicinal.
Below we present a more detailed description of 
these species (Table 1).
AIM AND METHODS
The object of our study are the medicinal and 
semi-medicinal species of the Lycopodiophyta repre-
sentatives of the flora of Ukraine. The basis of the 
work is the data obtained during the field research 
as a result of working on literary materials and maps, 
and herbarium collections of Ukraine gathered in 
the period 2010–2019. 
RESULTS AND DISCUSSION
Lycopodiophyta species are of no economic val-
ue in Ukraine due to several reasons. The results of 
the study are presented in Table 1 in which the check-
list of representatives of the studied department is 
given in alphabetical order. The name of each spe-
cies is in Latin and English (9 species), presented are 
also family, distribution in Ukraine, resource value, 
population structure, conservation status in Ukraine 
and Europe, main active substances, and medicinal 
properties.
We analyzed the distribution of plant spe-
cies in Ukraine and established that the majority ‒ 
42% (5 species) — is known from several localities, 
mainly growing in the Carpathians and Polissya 
(10,12,13,15,16).
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After analyzing the State Register of Medici-
nal Products of Ukraine (14) we found out that most 
of the available drugs on the territory of Ukraine are 
manufactured and purchased abroad (Table 2).
In addition to the above-mentioned compre-
hensive homeopathic medications, there is also a 
well-known cosmetic product ‒ a powder on the ba-
sis of dry extract of L. clavatum (double-acting pow-
der), which has a calming effect, and helps to reduce 
irritation and redness. The country of origin of the 
product is Israel.





Biologische Heilmittel Heel 
GmbH., Germany






Biologische Heilmittel Heel 
GmbH., Germany
Biologische Heilmittel Heel 
GmbH., Germany
HEPEEL® N Lycopodium clavatum 
Biologische Heilmittel Heel 
GmbH., Germany
Biologische Heilmittel Heel 
GmbH., Germany
HEPEEL® Lycopodium clavatum 
Biologische Heilmittel Heel 
GmbH., Germany






Biologische Heilmittel Heel 
GmbH., Germany






Biologische Heilmittel Heel 
GmbH., Germany






Biologische Heilmittel Heel 
GmbH., Germany
Biologische Heilmittel Heel 
GmbH., Germany
WEIGHT NORM Lycopodium clavatum 
PC “National Homeopathic 
Union”, Ukraine
PC “National Homeopathic 
Union”, Ukraine
HOLE-GRAN Lycopodium 
PC “National Homeopathic 
Union”, Ukraine;
Ferrer Internacional, S.A., Spain
PC “National Homeopathic 
Union”, Ukraine;
Ferrer Internacional, S.A., Spain
SCLERO-GRAN Lycopodium clavatum 
PC “National Homeopathic 
Union”, Ukraine






Biologische Heilmittel Heel 
GmbH., Germany
Biologische Heilmittel Heel 
GmbH., Germany
ENERCEL® PLUS I. М Lycopodium clavatum  Laboratories Vijosa S.A. de C.V. Laboratories Vijosa S.A. de C.V.
ENERCEL® FORTE Lycopodium clavatum  Laboratories Vijosa S.A. de C.V. Laboratories Vijosa S.A. de C.V.
SOLVENCIUM Lycopodium clavatum  PC “Biolik”






Pecana Heilmittel Heel GmbH., 
Germany
Pecana Heilmittel Heel GmbH., 
Germany
*Drugs are in bold and underlined - the term of registration has expired.
Table 2. Medications containing Lycopodium represented in the State Register of Medicines, Ukraine 
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Medication containing Lycopods is also used in 
veterinary medicine. For example, Liarsin, which in-
cludes L. clavatum, is a complex homeopathic prod-
uct, which has a corrective effect on protein, hydro-
carbon, metabolism, restores impaired gastrointesti-
nal function, stimulates the body’s immune system. 
Its country of origin is Russia.
However, it should be noted that Lycopods have 
poisonous properties and thier use should be carried 
out under medical supervision.
It is likely that this situation with the research 
and use of Lycopods is primarily conditioned by the 
absence of a raw material base in Ukraine and their 
conservation status.
CONCLUSION
The results obtained from the use of Lycopodi-
ophyta indicate that there is no medical or any oth-
er economic importance in Ukraine. Most species of 
Lycopods are distributed only in certain regions and 
have a conservation status. The populations of the 
studied species are few and sensitive to anthropogen-
ic factors. Most homeopathic preparations contain-
ing Lycopods are produced in other countries, which 
is caused by a number of factors listed above.
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